Epidarex invests in early-stage,
high growth life science and health technology companies
in emerging and under-ventured research
within the UK and US
Epidarex Provides Equity Capital to Start-Ups, Including University Spin-outs
Through our deep scientific and industry network we are able to identify transformative life science investments in under-ventured regions of the US and UK, building companies from scratch to create value and shared success.
Our international management team has a track record of successfully partnering with scientists and entrepreneurs to develop highly innovative products for the global healthcare market. We leverage our extensive relationships, industry operating experience and a disciplined investment approach to add significant value to our portfolio companies and to generate strong returns on investment for our investors.
We believe in working closely with the management of our portfolio companies to drive the translation of their research into world-class businesses.
Our global network includes investment professionals, scientists, industry executives, health practitioners, policy experts, regulatory advisors and business development leaders. This strong network contributes significantly to the growth and development of our portfolio companies.